Champix helps to break the pharmacologic basis of addiction¹ in two ways, helping patients to be smoke-free and nicotine-free.^2-4

Read about CHAMPIX warnings and precautions

1.  Benowitz NL. Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics. Annu Rev Pharmacol Toxicol 2009; 49: 57-71.
2. CHAMPIX Summary of Product Characteristics.
3. Gonzales D, Rennard Sl, Nides M et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained release bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA 2006; 296: 47-55.
4. West R, Baker CL, Cappelleri JC et al. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology 2008; 197: 371-377.
 

PP-CHM-GBR-2819. April 2019